Sunshine Biopharma Inc. Warrant (SBFMW)
$0.03
As on 31-Aug-2026 15:48EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
10 Years Aggregate
CFO
$-19.78 Mln
EBITDA
$-25.13 Mln
Net Profit
$-56.66 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sunshine Biopharma Inc. Warrant (SBFMW)
| -83.7 | -27.9 | -63.6 | -80.1 | -48.0 | -- | -- |
|
BSE Sensex*
| -10.7 | -3.7 | 1.8 | -6.4 | 4.5 | 5.3 | 10.1 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Sunshine Biopharma Inc. Warrant (SBFMW)
| 18.1 | -19.3 | -38.9 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Sunshine Biopharma Inc. Warrant (SBFMW)
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is... developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida. Read more
-
CFO & Secretary
Mr. Camille Sebaaly
-
CFO & Secretary
Mr. Camille Sebaaly
-
Headquarters
Fort Lauderdale, FL
-
Website
FAQs for Sunshine Biopharma Inc. Warrant (SBFMW)
What is the current share price of Sunshine Biopharma Inc Warrant (SBFMW) Today?
The share price of Sunshine Biopharma Inc Warrant (SBFMW) is $0.03 (NASDAQ) as of 31-Aug-2026 15:48 EDT. Sunshine Biopharma Inc Warrant (SBFMW) has given a return of -47.96% in the last 3 years.
What is the current PB & PE ratio of Sunshine Biopharma Inc Warrant (SBFMW)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.02 |
0.00 |
2024 |
-0.08 |
0.02 |
2023 |
0.00 |
0.00 |
2022 |
-0.03 |
0.03 |
2021 |
-- |
-- |
What is the 52 Week High and Low of Sunshine Biopharma Inc Warrant (SBFMW)?
The 52-week high and low of Sunshine Biopharma Inc Warrant (SBFMW) are Rs 0.65 and Rs 0.02 as of 08-Sep-2026.
What is the market cap of Sunshine Biopharma Inc Warrant (SBFMW)?
Sunshine Biopharma Inc Warrant (SBFMW) has a market capitalisation of -- as on 31-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Sunshine Biopharma Inc Warrant (SBFMW)?
Before investing in Sunshine Biopharma Inc Warrant (SBFMW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.